Respiratory morbidity of preterm infants of less than 33 weeks gestation without bronchopulmonary dysplasia: a 12-month follow-up of the CASTOR study cohort
Abstract
The aim of this study was to describe the incidence and risk factors for respiratory morbidity during the 12-month period following the first respiratory syncytial virus (RSV) season in 242 preterm infants [<33 weeks gestational age (GA)] without bronchopulmonary dysplasia and 201 full-term infants (39-41 weeks GA) from the French CASTOR study cohort. Preterm infants had increased respiratory morbidity during the follow-up period compared to full-terms; they were more likely to have wheezing (21% vs. 11%, P = 0•007) and recurrent wheezing episodes (4% vs. 1%, P = 0•049). The 17 infants (14 preterms, three full-terms) who had been hospitalized for RSV-confirmed bronchiolitis during their first RSV season had significantly more wheezing episodes during the follow-up period than subjects who had not been hospitalized for RSVconfirmed bronchiolitis (odds ratio 4•72, 95% confidence interval 1•71-13•08, P = 0•003). Male gender, birth weight <3330 g and hospitalization for RSV bronchiolitis during the infant's first RSV season were independent risk factors for the development of wheezing episodes during the subsequent 12-month follow-up period.
Fichier principal
respiratory-morbidity-of-preterm-infants-of-less-than-33-weeks-gestation-without-bronchopulmonary-dysplasia-a-12-month-follow-up-of-the-castor-study-cohort.pdf (198.19 Ko)
Télécharger le fichier
| Origin | Publication funded by an institution |
|---|
